Search PubMed⌕ Search

Biomedical subjects

G C Field

Publications and source records attributed to G C Field.

3 recordsLinked to original sources

Shielding considerations for tomotherapy.

Tomotherapy presents an evolutionary modality that holds forth the promise of better dose conformation to tumor volumes with a concomitant reduction in radiation-induced damage to surrounding normal structures. This delivery technique also presents a new set of radiation protection challenges that impact upon the design of the shielding vault required to house such a unit. A formalism is presented to determine the requisite amounts of shielding for both the primary beam and leakage radiation associated with a generic tomotherapy unit. A comparison is made with the shielding requirements for a conventional linear accelerator operated in a standard manner. Substantial differences in the amount of both primary and secondary shielding are indicated. A tomotherapy primary beam shield is both reduced in width by a factor of almost 10 and increased in thickness by more than a tenth value layer in comparison to a conventional accelerator. Furthermore, the secondary shielding requirements are enhanced by more than two tenth value layers with respect to conventional shielding demands.

Humans↗

Evaluation of optimized compensators on a 3D planning system.

A commercially available treatment planning system contains several functions that allow for the automation of missing tissue and optimized compensators, where the former retracts the bolus toward the source, and the latter attempts, by iteration, to establish a uniform dose at some user defined depth. The intent of this paper is to report on the compensators designed by the system and to compare them to those devised through conventional techniques. It is demonstrated that the system can model the dosimetric effects of compensators with a high degree of accuracy; measured and predicted doses agree to within 3%. Optimized compensators show slightly improved dose uniformity over thickness reduced compensators. Both show significantly improved uniformity over compensators that simply retract the bolus geometry. In cases where internal inhomogeneities exist, however, the dose uniformity from the optimized compensators vary by as much as 6% at the target depth. These deviations are comparable to the errors of the inhomogeneity algorithm itself. The pathlength reduction technique has been applied to both missing tissue and inhomogeneity compensation, and it has been found that for inhomogeneity compensation, the pathlength reduced compensators produce more uniform distributions than those generated by the optimization algorithm.

Algorithms↗